[The effect of tactivin and the intraduodenal administration of drug mixtures on the efficacy of the therapy of duodenal peptic ulcer].
Incorporated into the complex of therapeutic measures to treat duodenal ulcer associated with Helicobacter pylori (H. p.) were tactivin and intraduodenal administration of drug mixtures made up of pharmaco- and phytopreparations. Effectiveness of treatment was to be evidenced by healing of the ulcer defect, elimination of H. p. from the mucous membrane, and length of clinico-endoscopic remission. The greatest benefit from treatment occurred when tactivin was used in combination with intraduodenal administration a mixture of rotocan, olazol, proposol, methiluracil, and trychopol.
Katerenchuk
I P
IP
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D004333:Drug Administration Routes; D004338:Drug Combinations; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy*; D004386:Duodenum; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage*; D010936:Plant Extracts / Q000008:administration & dosage; D013949:Thymus Extracts / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D000897:Anti-Ulcer Agents; D004338:Drug Combinations; D010455:Peptides; D010936:Plant Extracts; D013949:Thymus Extracts; C036191:T-activin